Curran Terrie bought ARQT
August 27, 2026 · Form 4 insider transaction
Curran Terrie bought 11,148 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $83.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,148
Price
$7.51
Total value
$83.7K
InsiderCurran Terrie
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 27, 2026
Filing dateAugust 28, 2026
Shares owned after34,674
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.